# A Study of TNFerade™ Biologic With Concomitant Radiotherapy, Fluorouracil, and Hydroxyurea (TNF-FHX) in Patients With Head and Neck Cancer

> **NCT00496535** · PHASE1,PHASE2 · COMPLETED · sponsor: **GenVec**

## Conditions studied

- Head and Neck Cancer
- Head and Neck Neoplasms

## Interventions

- **DRUG:** TNFerade biologic

## Key facts

- **NCT ID:** NCT00496535
- **Lead sponsor:** GenVec
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2012-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00496535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00496535, "A Study of TNFerade™ Biologic With Concomitant Radiotherapy, Fluorouracil, and Hydroxyurea (TNF-FHX) in Patients With Head and Neck Cancer". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00496535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*